386 related articles for article (PubMed ID: 33300082)
1. Wnt/β‑catenin signaling: Causes and treatment targets of drug resistance in colorectal cancer (Review).
Zhu GX; Gao D; Shao ZZ; Chen L; Ding WJ; Yu QF
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300082
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic strategies targeting Wnt/β‑catenin signaling for colorectal cancer (Review).
Ji Y; Lv J; Sun D; Huang Y
Int J Mol Med; 2022 Jan; 49(1):. PubMed ID: 34713301
[TBL] [Abstract][Full Text] [Related]
3. Blocking the Wnt/β‑catenin signaling pathway to treat colorectal cancer: Strategies to improve current therapies (Review).
Chen Y; Chen M; Deng K
Int J Oncol; 2023 Feb; 62(2):. PubMed ID: 36579676
[TBL] [Abstract][Full Text] [Related]
4. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB
Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of aquaporin-5 sensitizes colorectal cancer cells to 5-fluorouracil via inhibition of the Wnt-β-catenin signaling pathway.
Li Q; Yang T; Li D; Ding F; Bai G; Wang W; Sun H
Biochem Cell Biol; 2018 Oct; 96(5):572-579. PubMed ID: 29390193
[TBL] [Abstract][Full Text] [Related]
6. Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors.
Ayadi M; Bouygues A; Ouaret D; Ferrand N; Chouaib S; Thiery JP; Muchardt C; Sabbah M; Larsen AK
Oncotarget; 2015 Jul; 6(21):18518-33. PubMed ID: 26041882
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA‑8063 targets heterogeneous nuclear ribonucleoprotein AB to inhibit the self‑renewal of colorectal cancer stem cells via the Wnt/β‑catenin pathway.
Chen ZQ; Yuan T; Jiang H; Yang YY; Wang L; Fu RM; Luo SQ; Zhang T; Wu ZY; Wen KM
Oncol Rep; 2021 Oct; 46(4):. PubMed ID: 34396427
[TBL] [Abstract][Full Text] [Related]
8. Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance.
Hu YB; Yan C; Mu L; Mi YL; Zhao H; Hu H; Li XL; Tao DD; Wu YQ; Gong JP; Qin JC
Oncogene; 2019 Mar; 38(11):1951-1965. PubMed ID: 30390075
[TBL] [Abstract][Full Text] [Related]
9. miR‑576‑5p promotes epithelial‑to‑mesenchymal transition in colorectal cancer by targeting the Wnt5a‑mediated Wnt/β‑catenin signaling pathway.
Luo J; Liu L; Shen J; Zhou N; Feng Y; Zhang N; Sun Q; Zhu Y
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300054
[TBL] [Abstract][Full Text] [Related]
10. FOXM1/DVL2/Snail axis drives metastasis and chemoresistance of colorectal cancer.
Yang Y; Jiang H; Li W; Chen L; Zhu W; Xian Y; Han Z; Yin L; Liu Y; Wang Y; Pan K; Zhang K
Aging (Albany NY); 2020 Dec; 12(23):24424-24440. PubMed ID: 33291076
[TBL] [Abstract][Full Text] [Related]
11. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W
J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364
[TBL] [Abstract][Full Text] [Related]
12. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
Shi L; Xi J; Xu X; Peng B; Zhang B
Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer.
Wang X; Ghareeb WM; Zhang Y; Yu Q; Lu X; Huang Y; Huang S; Sun Y; Chi P
J Cell Physiol; 2019 Aug; 234(10):18180-18191. PubMed ID: 30859572
[TBL] [Abstract][Full Text] [Related]
14. Effects of LDOC1 on colorectal cancer cells via downregulation of the Wnt/β-catenin signaling pathway.
Jiang J; Li Y; Jiang Z
Oncol Rep; 2019 Jun; 41(6):3281-3291. PubMed ID: 31002361
[TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment involvement in colorectal cancer progression
Novoa Díaz MB; Martín MJ; Gentili C
World J Gastroenterol; 2022 Jul; 28(26):3027-3046. PubMed ID: 36051330
[TBL] [Abstract][Full Text] [Related]
16. Non-coding RNAs Functioning in Colorectal Cancer Stem Cells.
Fanale D; Barraco N; Listì A; Bazan V; Russo A
Adv Exp Med Biol; 2016; 937():93-108. PubMed ID: 27573896
[TBL] [Abstract][Full Text] [Related]
17. Pimozide suppresses colorectal cancer via inhibition of Wnt/β-catenin signaling pathway.
Ren Y; Tao J; Jiang Z; Guo D; Tang J
Life Sci; 2018 Sep; 209():267-273. PubMed ID: 30107167
[TBL] [Abstract][Full Text] [Related]
18. KHDRBS3 promotes multi-drug resistance and anchorage-independent growth in colorectal cancer.
Ukai S; Sakamoto N; Taniyama D; Harada K; Honma R; Maruyama R; Naka K; Hinoi T; Takakura Y; Shimizu W; Ohdan H; Yasui W
Cancer Sci; 2021 Mar; 112(3):1196-1208. PubMed ID: 33423358
[TBL] [Abstract][Full Text] [Related]
19. Comparative profiling between primary colorectal carcinomas and metastases identifies heterogeneity on drug resistance.
Luo F; Li J; Wu S; Wu X; Chen M; Zhong X; Liu K
Oncotarget; 2016 Sep; 7(39):63937-63949. PubMed ID: 27613840
[TBL] [Abstract][Full Text] [Related]
20. Role of Wnt/
Yuan S; Tao F; Zhang X; Zhang Y; Sun X; Wu D
Biomed Res Int; 2020; 2020():9390878. PubMed ID: 32258160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
